BPMC - Blueprint Medicines EPS beats by $0.26 beats on revenue November, 05 2019 07:10 AM Blueprint Medicines Corporation Blueprint Medicines (NASDAQ:BPMC): Q3 GAAP EPS of -$1.93 beats by $0.26.More news on: Blueprint Medicines Corporation, Earnings news and commentary, Healthcare stocks news, Read more ...